维普中文期刊产品整合服务
79篇 您的检索式:作者名="Shaughnessy JA"
    题名 作者 年代 出处 被引量
1Genome and tran-scriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnerabilities显示文摘Craig DW O'Shaughnessy JA Kiefer JA 0,,01:1
2Commentary concerning demonstration of safety and efficacy of investigational anticancer agents in clinical trials显示文摘O'Shaughnessy JA Wittes RE Burke G 1991J Clin Oncol1991,9,:1
3Skeletal and dental changes following functional regulator therapy on class II patients显示文摘McNamara JA Jr Bookstein FL Shaughnessy TG 1985Am J Orthod1985,88,2:1
4Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy显示文摘O'Shaughnessy JA Vukelja SJ Holmes FA 2005Clin Breast Cancer2005,5,6:1
5Re-infection following sustained virological response with a different hepatitis C virus genotype: implications for infection control policy显示文摘O'shaughnessy MM Oi'egan JA Murray FE 2012Clin Kidney J2012,5,3:1
6Docetaxel with cyclophosphamide is associated with an overal survival benefit compared to doxorubicin and cyclophosphamide:7-year followup of US Oncology Research Trial 9735显示文摘Jones SE Holmes FA O'Shaughnessy JA 2009J Clin Oncol2009,27,10:1
7Commentary concerning demonstration of safety and efficacy of invest- igational anticancer agents in clinical trials显示文摘O'Shaughnessy JA Wittes RE Burke G J C1 in On- col0,,9:1
8Cardiac toxicity of trastuzumab-related regimens in HER2-overexpressing breast cancer 显示文摘WER MS O'SHAUGHNESSY JA 2007Clin Breast Cancer2007,7,8:1
9Blinded,randomized,multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer显示文摘HOLMES FA O'SHAUGHNESSY JA VUKELJA S 2002J Clin Oncol2002,20,3:1
10Blinded, randomized, multieenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage Ⅱ or stage Ⅲ/Ⅳ breast cancer显示文摘Holmes FA O' Shaughnessy JA Vukelja S 2002J Clin Oncol2002,20,3:1
11Blinded,randomized,multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer显示文摘Holmes FA O'Shaughnessy JA Vukelja S 2002J Clin Oncol2002,20,3:1
12Phase Ⅱ,Randomized,Double-Blind Study of Two Dose Levels of Arzoxifene in Patients with Locally Advanced or Metastatic Breast Cancer显示文摘Buzdar A O'Shaughnessy JA Booser DJ 2003J Clin Oncol2003,21,6:1
13Commentary concerning demonstration of safety and efficacy of investigational anticancer agents in clinical trials 显示文摘O'Shaughnessy JA Wittes RE Burke G 1991J Clin Oncol1991,9,12:1
14Commentary con-cerning demonstration of safety and efficacy of investigational anti-cancer agents in clinical trial显示文摘O’Shaughnessy JA Wittes RE Burke G 1991J Clin Oncol1991,9,12:1
15Phase Ⅱ study of trastuzumab plus gemcitabine in chemotherapy-pretreated patients with metastatic breast cancer 显示文摘O'Shaughnessy JA Vukelja S Marsland T 2004Clin Breast Cancer2004,5,:1
16Treatment and prevention of intraepithelial neoplasia:an important target for accelerated new agent development 显示文摘Shaughnessy JA Kelloff GJ Gordon GB 2002Clin Cancer Res2002,8,:1
17Phase Ⅱ study of pemetrexed in patients pretreated with an anthracycline, a taxane, and eapecitabine for advanced breast cancer 显示文摘O Shaughnessy JA Clark RS Blum JL 2005Clin Breast Cancer2005,6,2:1
18Blin-ded,randomized,multicenter study to evaluate single administra-tion pegfilgrastim once per cycle versus daily filgrastim as an ad-junct to chemotherapy in patients with high-risk stage II or stageIII/IV breast cancer 显示文摘HOLMES FA O’SHAUGHNESSY JA VUKELJA S 2002J Clin Oncol2002,20,3:1
19Multiple Venous Thromboses Presenting as Mechanical Low Back Pain in an 18-Year-Old Woman显示文摘Marehand AA Boucher JA O'Shaughnessy J 2015J Chiropr Med2015,14,2:1
20Commentary concerning demonstration of safety and efficacy of investlgational anticancer agents in climical trials显示文摘O' Shaughnessy JA Wittes RE Burke G 1991J Clin Oncol1991,9,:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费